Literature DB >> 1702629

Intact Alzheimer amyloid precursor protein (APP) is present in platelet membranes and is encoded by platelet mRNA.

J E Gardella1, J Ghiso, G A Gorgone, D Marratta, A P Kaplan, B Frangione, P D Gorevic.   

Abstract

Using antibodies directed against N-terminal and C-terminal epitopes we have immunologically detected APP species in the membrane and saline-soluble fractions of unstimulated platelets, and in the conditioned medium of thrombin-stimulated platelets. These studies demonstrate an intact 140 kD membrane-associated form of APP that is released on degranulation. Evidence that platelets synthesize at least one form of APP (APP751) was obtained by enzymatic amplification of specific mRNA using Polymerase Chain Reaction (PCR) and direct sequence analysis of PCR product. Processing of APP for release may occur via successive C-terminal truncations, and/or by the release and proteolysis of an intact membrane associated form. An intact form of APP in platelets provides a circulating substrate upon which proteases from many tissues may act to produce beta protein (AB) during pathologic conditions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1702629     DOI: 10.1016/s0006-291x(05)80927-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Expression and Processing of Amyloid Precursor Protein in Vascular Endothelium.

Authors:  Livius V d'Uscio; Tongrong He; Zvonimir S Katusic
Journal:  Physiology (Bethesda)       Date:  2017-01

2.  Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor.

Authors:  J D Buxbaum; M Oishi; H I Chen; R Pinkas-Kramarski; E A Jaffe; S E Gandy; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

3.  A 109-amino-acid C-terminal fragment of Alzheimer's-disease amyloid precursor protein contains a sequence, -RHDS-, that promotes cell adhesion.

Authors:  J Ghiso; A Rostagno; J E Gardella; L Liem; P D Gorevic; B Frangione
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

4.  The spatial patterns of beta/A4 deposit subtypes in Alzheimer's disease.

Authors:  R A Armstrong; D Myers; C U Smith
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

Review 5.  Insights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer's disease.

Authors:  Edgar Dawkins; David H Small
Journal:  J Neurochem       Date:  2014-03-07       Impact factor: 5.372

6.  Platelet dysfunction in hypercholesterolemia mice, two Alzheimer's disease mouse models and in human patients with Alzheimer's disease.

Authors:  Barbara Plagg; Josef Marksteiner; Kathrin M Kniewallner; Christian Humpel
Journal:  Biogerontology       Date:  2015-05-07       Impact factor: 4.277

7.  Heteromers of amyloid precursor protein in cerebrospinal fluid.

Authors:  Inmaculada Cuchillo-Ibañez; Inmaculada Lopez-Font; Alba Boix-Amorós; Gunnar Brinkmalm; Kaj Blennow; Jose-Luis Molinuevo; Javier Sáez-Valero
Journal:  Mol Neurodegener       Date:  2015-01-08       Impact factor: 14.195

8.  Alzheimer disease and platelets: how's that relevant.

Authors:  Silvia Catricala; Mauro Torti; Giovanni Ricevuti
Journal:  Immun Ageing       Date:  2012-09-17       Impact factor: 6.400

9.  Platelets isolated from an Alzheimer mouse damage healthy cortical vessels and cause inflammation in an organotypic ex vivo brain slice model.

Authors:  Kathrin M Kniewallner; Bettina M Foidl; Christian Humpel
Journal:  Sci Rep       Date:  2018-10-19       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.